Anika Therapeutics
ANIK
ANIK
109 hedge funds and large institutions have $206M invested in Anika Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
36% less capital invested
Capital invested by funds: $324M → $206M (-$117M)
44% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 27
Holders
109
Holding in Top 10
3
Calls
$47K
Puts
$31K
Top Buyers
| 1 | +$6.66M | |
| 2 | +$1.96M | |
| 3 | +$1.1M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.01M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$805K |
Top Sellers
| 1 | -$4.34M | |
| 2 | -$3.4M | |
| 3 | -$3.38M | |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$2.69M |
| 5 |
RP
Riverwater Partners
Milwaukee,
Wisconsin
|
-$2.55M |